Initial Management of Periampullary Mass

Diagnostic Workup Algorithm

Abdominal ultrasound is the most useful initial investigation, with 80-95% sensitivity for detecting pancreatic/periampullary tumors while simultaneously identifying biliary obstruction and hepatic metastases 1, 3, 4
Proceed to contrast-enhanced helical CT scan with arterial and portal venous phases, which accurately predicts resectability in 80-90% of cases 2, 3, 4
CT reliably demonstrates the primary tumor, vascular involvement, hepatic metastases, and lymph node involvement 2, 4

ERCP should be performed when direct visualization and biopsy of ampullary tumors is needed, as ERCP allows direct visualization and tissue sampling 3, 4
ERCP is also indicated when biliary stenting is required for symptomatic jaundice relief 3
Endoscopic ultrasound (EUS) is indicated when small tumors need detection, assessment of vascular invasion is critical, or fine-needle aspiration for cytology is needed in select cases 4
Laparoscopy with laparoscopic ultrasound should be considered when detection of occult peritoneal or hepatic metastases not visible on other imaging is needed 4

Attempts should be made to obtain tissue diagnosis during endoscopic procedures 5
Avoid transperitoneal fine-needle aspiration in potentially resectable tumors due to risk of peritoneal seeding that could eliminate curative potential 2, 3
Tissue diagnosis is essential for patients selected for palliative therapy 5

Signs of unresectability include persistent back pain, severe rapid weight loss, palpable abdominal mass, ascites, or supraclavicular lymphadenopathy (Virchow's node) 1, 3, 6
Portal vein encasement on imaging and hepatic or distant metastases are also signs of unresectability 2, 5

Do not perform percutaneous biliary drainage prior to resection in jaundiced patients, as it does not improve surgical outcomes and may increase infective complications 5
Avoid routine use of angiography, as CT/MR provides equivalent vascular information non-invasively 2, 4
Jaundice in periampullary tumors indicates earlier-stage disease with higher resectability compared to pancreatic body/tail tumors 1, 6

All patients should be managed by specialist centers to increase resection rates and reduce morbidity and mortality 5
Proper pathological interpretation requires specialist expertise, particularly for rare tumor variants 7, 8